NovoLog Mix 70/30
- Product NDC
- 50090-4074
- 11-digit product format
- 500904074
- Labeler code
- 50090
- Product ID
- 50090-4074_1efe8a76-4799-4e9f-b686-543071d912ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin aspart
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- BLA021172
- Marketing category
- BLA
- Marketing start
- 2001-11-01
- Marketing end
- 0000-00-00
- Substance
- INSULIN ASPART
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin Analog [EPC], Insulin [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50090-4074 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 50090-4074 | 50090-4074-0 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50090-4074-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50090-4074-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50090-4074-0 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50090-4074-0 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50090-4074-0 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50090-4074-0 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50090-4074-0 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50090-4074-0 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50090-4074-0 | 0efc9e666f02… | f202fb6c5f17… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4074-0 | ML - Milliliter | 50090-4074 | ac90af5e-65e1-4ff1-a814-dee4b848dc9c | 1 | 2024-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NovoLog Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 66da64f7-ca50-47d2-95fa-de37005eef85 | 2026-05-18 | Warnings, Adverse reactions | BLA021172 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 5d9f0e10-edb9-4960-bd62-cf406e75bbe7 | 2026-04-07 | Warnings, Adverse reactions | BLA021172 |
| NovoLog Mix 70/30 | INSULIN ASPART | A-S Medication Solutions | 19888a44-b330-462a-864d-338c5893dd63 | 2026-01-29 | Warnings, Adverse reactions | BLA021172 |
| .Insulin Aspart Protamine and Insulin Aspart | INSULIN ASPART | A-S Medication Solutions | 14499781-b90e-47d5-a7de-006965439b94 | 2024-02-22 | Warnings, Adverse reactions | BLA021172 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | Novo Nordisk Pharma, Inc. | fc94baa4-3606-48bc-a781-9617ab6960ef | 2023-02-28 | Warnings, Adverse reactions | BLA021172 |
| NovoLog Mix 70/30 | INSULIN ASPART | Novo Nordisk | 1861fcee-7673-4afe-a206-08fa05c0add2 | 2023-02-28 | Warnings, Adverse reactions | BLA021172 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021172 | Novolog Mix 70/30 | insulin aspart protamine and insulin aspart | 351(a) | Rx | 2026-07-01 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-4074-0 | 50090407400 | 1 VIAL, GLASS in 1 CARTON (50090-4074-0) > 10 mL in 1 VIAL, GLASS | 2019-01-21 | 0000-00-00 | No | No | Current |